# Commission Regulation (EU) No 1154/2014 of 29 October 2014 refusing to authorise certain health claims made on foods, other than those referring to the reduction of disease risk and to children's development and health (Text with EEA relevance), Annex: REJECTED HEALTH CLAIMS

Extent: E+W+S+N.I.

Application — Relevant provisions of Regulation (EC) No 1924/2006
Nutrient, substance, food or food category
Claim
EFSA opinion reference
Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data
Zinc
Prevents bad breath by neutralising of volatile sulphur compounds (VSC) in the mouth and oral cavity.
Q-2010-01092
Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data
Yestimun®
Daily administration of Yestimun® helps to maintain the body's defence against pathogens.
Q-2012-00761
Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data
Transitech®
Improves transit and durably regulates it.
Q-2013-00087
Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data
Bimuno® GOS
Regular daily consumption of 1,37 g galacto-oligosaccharides from Bimuno® may reduce abdominal discomfort.
Q-2012-01007
Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data
Lactobacillus rhamnosus GG
Lactobacillus rhamnosus GG for maintaining normal defecation during oral antibiotic treatment.
Q-2013-00015
Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data
VeriSol®P
Characteristic collagen peptide mixture (collagen hydrolysate) having a beneficial physiological effect on the maintenance of skin health, as indicated by an increased skin elasticity and a reduction of wrinkles volume, by contributing to a normal collagen and elastin synthesis.
Q-2012-00839
Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data
Proanthocyanidins in Urell®
Proanthocyanidins from Urell® contribute to support defence against bacterial pathogens in the lower urinary tract
Q-2012-00700
Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data
Preservation®
Improves the physiological response to stress by accelerating the appearance of heat shock proteins (HSPs) and maintains an effective level of HSPs to ensure that the organism is primed should the cell encounter further stress.
Q-2013-00021

---
Source: https://www.legislation.gov.uk/eur/2014/1154/annex (the official version)
Page: https://openlegislation.uk/eu-regulation-2014-1154/annex
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.